Prospective genomic surveillance reveals cryptic MRSA outbreaks with local to international origins among NICU patients

Jay N. Worley, Jessica W. Crothers, William J. Wolfgang, Sai Laxmi Gubbala Venkata, Maria Hoffmann, Victor Jayeola, Michael Klompas, Marc Allard, Lynn Bry
doi: https://doi.org/10.1101/2021.07.14.21260339

Abstract

MRSA infections cause significant morbidity and mortality in neonates. Clinical testing and routine surveillance screening identified an increase in neonates with MRSA colonization and infection which triggered prospective genomic surveillance. Here we show the complex transmission dynamics of MRSA in a NICU setting. Analyses revealed concurrent transmission chains affecting 16 of 22 MRSA-colonized patients (68%), and 3.1% of all NICU patients (n=517). Prematurity and longer lengths of stay increased risks for colonization. Intervals of up to 7 months occurred among some cluster-related isolates. 3 of 22 MRSA-colonized patients developed invasive infections with the colonizing strain. Comparisons with 21,521 isolates in the NCBI Pathogen Detection Resource revealed NICU strains to be distinct from MRSA seen locally and internationally. Integration of international strain datasets in analyses increased the resolution of strain clusters and helped rule-out suspected transmission events. Analyses also identified sequence type 1535 isolates, emergent in the Middle East, carrying a unique SCCmec with fusC and aac(6’)-Ie/aph(2’’)-1a that provided a multi-drug resistant phenotype. NICU genomic surveillance identified cryptic MRSA colonization events, including NICU-endemic strains not linked with local hospital or international clusters, and has rich potential to guide improvements in infection prevention for this vulnerable patient population.

Introduction

Staphylococcus aureus is a common cause of healthcare associated infections1,2. The pathogen can cause sepsis, respiratory and skin and soft tissue infections and is a major cause of patient morbidity and mortality3. Methicillin-resistant Staphylococcus aureus (MRSA) colonization is a well-recognized risk factor for infection4,5. Efforts to reduce infections have focused on decreasing MRSA transmission via institutional screening and decolonization6,7.

Neonatal populations in general, and pre-term and low birthweight infants in particular, are at increased risk of MRSA colonization and infection8-11 given their lack of protective colonizing microbiota and immature immune system4,12,13. Nosocomial transmission of S. aureus in neonates can occur among patients14-17, as well as from colonized healthcare workers18-20, parents21,22, and environmental reservoirs23. However, the relative contribution of these reservoirs remains controversial13,24. Additionally, neonatal intensive care units (NICUs) have witnessed a shift over the past twenty years from hospital acquired MRSA strains to community-acquired MRSA strains, requiring modifications in infection control practices for this patient population3,25.

Whole genome sequencing (WGS) enables epidemiologic outbreak investigations through high-resolution strain tracking26-29. While S. aureus outbreak investigations have historically used targeted molecular strain-typing, the discriminatory power of conventional techniques has been largely insufficient to establish definitive genomic and strain-specific linkages30. In contrast, WGS enables definitive clonal assessments and associated temporal relationships when combined with epidemiologic data31. Applied to NICU-populations, WGS has improved the detection of patient-to-patient17,27 and healthcare worker transmission events32-34, environmental reservoirs of infection23,35, and supported more effective MRSA screening programs36. Importantly, WGS can also rule-out nosocomial transmission events, providing reassurance to staff and appropriate utilization of hospital resources29,37.

The staphylococcal cassette chromosome mec (SCCmec) confers broad-spectrum resistance to beta-lactam antibiotics and is a common genetic cause for the MRSA phenotype. SCCmecs contain a mec gene encoding PBP2A, a peptidoglycan transpeptidase homolog of PBP2 with reduced affinity for beta-lactam antibiotics, particularly cephalosporins38. Many SCCmec types, as well as non-mec SCCs, encode other resistance genes such as the fusidic acid resistance gene fusC 38,39.

Observations of an increase in NICU MRSA colonizations and infections raised concerns for transmission events among neonates. Genomic analyses identified multiple cryptic outbreaks missed by clinical surveillance and diagnostic testing and also identified strain recurrences in distinct time periods that could not be attributed solely to patient-to-patient transmission. Expanded genomic analyses with >20,000 internationally deposited MRSA genomes in the NCBI Pathogen Detection resource significantly improved the phylogenetic resolution of local strain clusters and their dynamics of spread within the NICU, demonstrating the power of large-scale comparative genomic analyses for local hospital efforts to improve clinical and epidemiologic MRSA outbreak investigations.

Results

Antibiotic resistance phenotypes of NICU MRSA trigger prospective genomic surveillance

MRSA NICU isolates were evaluated phenotypically for similar antibiotic resistance profiles during a 341-day period over 2018-2019. Two suspected outbreaks during this targeted surveillance period triggered prospective genomic surveillance of all MRSA isolates from days 342-558, in addition to sequencing of prior available isolates from days 1-341 (Figure 1, Supplemental Figure 1). Over the 558 day period, 58 MRSA isolates, 55 screening and 3 diagnostic, were collected from 22 NICU patients. Of these patients, 16 neonates of 517 admitted during the prospective genomic surveillance period had MRSA isolates identified, representing 3.1% of NICU patients.

Figure 1.
Figure 1. NICU outbreak cluster occurrence:

X-axis indicates day during the analysis period. “Targeted Outbreak Sampling” refers to microbiologic-only assessments of NICU strains from days 0-341. Triangles and crosses indicate all occurring strains among patients that were also included in later genomic analyses. “Prospective surveillance” over days 342-558 indicates the period of prospective genomic analyses of new strains. Y-axis indicates NICU MRSA strains occurring in six NCBI, Pathogen Detection SNP clusters; numbers in parentheses indicate number of NICU strains from this study that occurred in the broader NCBI cluster, as follows: SNP Clusters (MLST, SCCmec type): 1, PDS000067849.1 (8, IVa(2B)); 2, PDS000069849.1 (72, IVa(2B); 3, PDS000069850.1 (5, II(2A)); 4, PDS000069851.1 (5, IVa(2B)); 5, PDS000069882.1 (1535, unclassified SCCmec); 6, PDS000069883.1 (8, IVa(2B)); Unc. = unclustered isolates with unrelated MLST and SCCmec types. SNP cluster 2 (NCBI outbreak cluster PDS000069849.1) contained only one isolate from this study (Supplemental File 2). Red dashed lines show a suspected outbreak during the, and a black dashed line marks when the Prospective Surveillance began.

Prematurity and increased NICU lengths of stay elevate risks for MRSA colonization

MRSA colonization was significantly associated with prematurity as well as low-birth-weight compared to non-colonized patients (Table 1, q=0.002; Supplemental Table 1). In addition to prematurity and low birth weight, MRSA-colonized patients had longer average lengths of stay in the NICU than non-colonized patients at 52.5 days (±34.8 days) versus 20.0 days (±24.8 days) (p < 0.001). Prematurity was also associated with longer NICU lengths of stay than patients carried to term (defined as >36 weeks of gestation), at 29.7 days (±29.3 days) versus 6.8 days (±7.2 days), respectively (Supplemental Table 2).

Genomic analyses identify 4 outbreak SNP clusters and unique NICU patient isolates

Genomic analyses using NCBI’s Pathogen Detection Resource identified 6 SNP clusters that accounted for 91.2% of sequenced NICU MRSA isolates originating from 17 of 22 MRSA-colonized patients (Figure 1). The remaining 5 patients with non-clustered MRSA strains each had short NICU admissions that yeilded only one isolate. These 5 patient-unique isolates showed no relationship to any S. aureus isolates deposited in NCBI and were not temporally linked to other NICU transmission events (Supplemental Figure 1).

SNP clusters 1, 3, 4, and 5, involved multiple patients (Figure 2). Clusters 1 and 3 were found across distinct time periods without patient overlap. The patient isolates in cluster 1 occurred in two separate intervals separated by 259 days, while strains in cluster 3 occurred across three time periods separated by 49 and 56 days (Figure 1). In contrast, clusters 4 and 5 occurred within single time periods. Among the two other NCBI-associated clusters, cluster 2 included one NICU isolate that clustered with an isolate reported from another institution, but was not clonally related (Supplemental File 2). Cluster 6 included two clonally-related isolates from the same patient that were separated by 5 SNPs. In total, 15 of 22 (68%) MRSA-colonized NICU patients, including all twins, and all cases of invasive disease occurred in clusters 1, 3, 4 and 5.

Figure 2.
Figure 2. SNP cluster analyses reveal patient outbreaks and occurrence over time.

Panels A-D show NICU MRSA strain phylogenetic trees from the NCBI Pathogen Genomes isolates browser with addition of the anonymized patientID and day of isolation. Graphs below each tree show the associated patients and strain occurrences relative to surveillance or diagnostic cultures. Though patient isolates fell within the broader NCBI SNP clusters, no other closely related strains from other institutions fell within these regions of the cluster SNP tree. Bar in each graph indicates 5 SNPs distance.

Comparisons of NICU strains in clusters 1, 3, 4 and 5 with adult nosocomial MRSA isolates seen at the hospital showed no clonal relationships between the populations, indicating that the outbreak clusters seen in the NICU were genomically distinct. Further, the NICU outbreak clusters did not include any of the 21,521 S. aureus isolate genomes deposited in NCBI’s Pathogen Isolates browser. To further assess nearest neighbor strains, whole-genome MLST (wgMLST) of NICU and 19,670 isolates with assemblies (Figure 3, Supplemental File 1, Supplemental File 2) confirmed that the NICU SNP clusters remained distinct even within broader wgMLST groups.

Figure 3.
Figure 3. International MRSA strain datasets support effective rule out of local NICU suspected transmission events.

Phylogenetic tree of NCBI ST5 SNP cluster isolates showing the NCBI SNP cluster, MLST and genomic SCCmec. The ST5 SNP clusters were downsampled to 5 representative isolates and wgMLST distances were used to define the 25 closest related strains in the NCBI Pathogen Detection program. SNPs within the wgMLST genes were used to calculate phylogenetic relationships Supplemental File 2). The outgroup strain (green) was most distantly related to the BWH strains by wgMLST SNPs. Bootstrap values are shown at phylogenetic nodes. NICU patient strains are shown in red, including 5 representative isolates from the 4 NICU patients in Cluster 4, and the additional MRSA isolate from patient 21. Bootstrap support values show placement of patient 21’s isolate in a separate sub-cluster distinct from Cluster 4.

International MRSA genomic datasets enable rule-out of putative transmission events

Analyses of Patient 21’s MRSA isolate showed an identical antibiogram, MLST, and SCCmec type to isolates found in NICU cluster 4. However, incorporating the additional external strain genomic datasets showed clear placement of this patient’s isolate in a genomically distinct cluster (Figure 3, Supplemental File 1).

A gain of the SCCmec type IVa (2B) is evident in the sub-clade of multi-locus sequence type (MLST) 5 including this isolate. Eight of the nine other closely related SCCmec type IVa (2B) strains were submitted by Mount Sinai Hospital in New York City, New York, and the 9th by the University of Pittsburgh Medical Center in Pittsburg, Pennsylvania. Thus, while Patient 21’s isolate and cluster 4’s isolates appear to belong to the same regional clade, this patient strain was ruled out as belonging to NICU cluster 4.

Genomic identification of internationally-occurring MRSA in NICU patients

Cluster 5 isolates, from patients 15 and 16 in twin set 3, included two nasal-perirectal swab isolates from patient 15 and one epidermal abscess isolate from patient 16. The three isolates belonged to MLST 1535 (Figure 4A). The twin’s parents had recently immigrated from the Middle East where this MLST is more prevalent40. While ST1535 appears to be rare in the US, one ST1535 genome from a pediatric cystic fibrosis patient in Cincinnati (GCA_002124405.1) was included in analyses41. The MLST 1535 genomes share the presence of three antibiotic resistance genes; aac(6’)-Ie/aph(2’’)-1a, fusC, and mecA (Figure 4B). High-resolution closed genomes of the cluster 5 isolates revealed an SCCmec region containing these resistance genes flanked by multiple mobilizing insertion sequences and novel repetitive elements that had not been resolvable in the draft-level genomic data (Figure 4C). The SSCmec contains ccrC and ccrAA with mecA allele C2, fusC in the J3 region and an IS256 flanked integron in the J1 region that contains aac(6’)-Ie-aph(2’’)-Ia38. Mobilizing IS431mec and IS256 were each found multiple times in this region, as well as a set of three direct repeats sharing a 13 base long core sequence not found elsewhere in the chromosome. The cluster 5 isolates demonstrated fusidic acid resistance at 8 µg/ml, oxacillin resistance at 2 or 0.5 µg/ml, and gentamicin resistance at ≥16 µg/ml (Supplemental File 1).

Figure 4.
Figure 4. Genomic analyses identify NICU MLST 1535 strains with international clusters similar resistance gene profiles and variant SCCmecs.

A. SNP based phylogeny of a wgMLST defined group of related strains reveals a clade of MLST 1535 strains from NICU Cluster 5 (red) that occurred in two patients. Strains were most similar to others identified in Saudi Arabia and one from Cincinnati. Strains outside of the MLST 1535 box are MLST 15. B. Antibiotic resistance gene profiles show the stepwise acquisition of resistance genes. The three NICU patient strains have lost lnuA and aac(6’)-Ie/aph(2’’)-Ia. C. A high-resolution genomic map of the SCCmec region from NCBI cluster 5 isolates closed by long-read genome sequencing. A 13 base AAACTAAAAAAT core sequence (DR1-DR3) with variable adjacent homologous sequence is directly repeated (DR) three times. This sequence does not appear elsewhere in the genome. Gradients in the IS element keys show directionality of the similar sequences.

Discussion

Preterm neonates are highly susceptible to colonization with pathogens, including MRSA, per their lack of colonization with a complex microbiota, immature immune system and frequent co-morbidities associated with preterm birth. Genomic analyses of surveillance and diagnostic MRSA cultures from NICU patients identified multiple outbreak clusters and transmission events. Many of these transmissions were cryptic events that fell below thresholds of detection using standard phenotypic assessments with clinical microbiologic data.

Four MRSA outbreaks associated with patient-to-patient transmission, clusters 1, 3, 4 and 5, occurred during the period of prospective genomic surveillance (Figures 1 and 2). These clusters accounted for isolates in 15 of 22 MRSA-colonized patients (68%) and all invasive MRSA infections. Genomic analyses provided high resolution information to resolve clusters and to also exclude putative transmission events in cases where strains co-occurring in time had identical microbiologic phenotypes. Geomic analyses resolved co-occurring MRSA strains among patients into three distinct clusters 1, 3, and 4. In addition, the sequence type 5 (ST5) isolate seen in surveillance cultures from patient 21 showed identical microbiologic phenotypes to strains in cluster 4 but a genomically distinct SNP profile allowing it to be ruled out as part of a transmission chain (Supplemental File 1). The higher resolution analyses enabling this distinction used 21,520 publicly-available genomic datasets from NCBI to resolve sub-clusters among ST5 strains (Figure 3). The external MRSA genomic data greatly improved the phylogenetic resolution of locally obtained strains and was thus able to rule out strain relatedness and further transmission events. Incorporation of large genomic datasets from geographically diverse regions enhances the accuracy of local genomic investigations of nosocomial outbreaks42.

We identified two potentially endemic strains in the NICU. Clusters 1 and 3 occurred over discontinuous time periods (Figure 1). Cluster 1 involved a NICU strain seen prior to initiating prospective genomic surveillance, with only 9 SNPs difference between the point of first detection of the cluster and its recurrence 259 days later (Figure 2). This finding concurs with prior literature showing that persistent strain carriage or presence on surfaces may accumulate low levels of SNP heterogeneity over time42-45. Similarly, cluster 3 isolates showed no consistent SNP differences while also appearing in three discontinuous time periods separated by 56 days and 49 days. Both clusters raise the possibility of sustained reservoirs that can seed intermittent outbreaks.

Two of four patients with isolates in cluster 4 developed invasive disease. Patient 12 had positive MRSA surveillance cultures 3 weeks in advance of infection while patient 14’s infection was detected on the same day as positive surveillance cultures (Figure 2C). In all cases, longitudinal MRSA isolates from individual patients and among twin sets were clonally related. Surveillance cultures therefore have predictive value for patients at higher risk for infections. However, patients 11, 15 and 16 were also co-colonized by methicillin sensitive S. aureus, demonstrating that colonization by multiple S. aureus strains can occur in NICU patients and can shift over time.

The use of extensive and geographically diverse datasets improved NICU-focused assessments of strain reservoirs and potential transmission events. The ST1535 isolate seen in patients 15 and 16 from twin set 3 (Figure 4, Supplemental Table 1) occurred primarily in locations from the Middle East, including clinical and environmental reservoirs46-48. While the parents and visiting family had recent international travel from the Middle East, domestic sources cannot be ruled out, as evidenced by a similar strain found in Cincinnatti41. Recent observations of confirmed and suspected MDR SCCs encoding mecA with other antimicrobial resistance genes, including several with fusC, raises concerns globally for Staphylococcal infections requiring complicated antimicrobial therapy49-51. fusC fusidic acid resistance has been seen in non-mec SCC and SCCmec elements49,52,53. The SCCmec sequence from the closed isolate genomes were highly similar to draft SCCmec sequences reported by Senok, et al.40. Closing of these isolate genomes identified clear IS431mec and IS256 sequences and additional direct repeats within the SCCmec that may facilitate accrual of additional resistance genes via further transposition or inter-recombination events with homologous mobile elements54.

All MRSA-colonized neonates had been admitted to the NICU for prematurity (Figure 2, Figure S1). Prematurity and associated long lengths of stay in the NICU elevate risks for MRSA colonization and infection4,5. Importantly, NICU-specific outbreak strains were found in 68% of MRSA-colonized patients (15 of 22 neonates). Prospective genomic surveillance thus offers a tool to rapidly identify related strains, aid the discovery of risk factors for transmission, define potential environmental or staff reservoirs, and thus inform interventions to halt further spread.

We demonstrate the application of longitudinal genomic surveillance in a NICU setting using international repositories of deposited strains to improve outbreak detection, including cryptic transmission events, and potential pathogen reservoirs. The addition of robust and gnomically diverse information improves the resolution of analyses and better enables critical rule-out determinations. Analyses also provide global context for uncommon strains that may be seen in an increasingly connected world.

Methods

IRB study protocol and data collection

The study was conducted under IRB protocol 2011-P-002883 (PI: Bry, Partners Healthcare). The Crimson LIMS was used for sample retrieval, and patient data and microbiological test results were retrieved using the Partners Research Patient Data Registry55,56. Data used for analyses were deidentified.

Study design and clinical interventions

From days 1-341 MRSA isolates flagged from prior clinical microbiologic testing or nasal-perirectal swab screening were saved for phenotypic analyses of susceptibility profiles to evaluate suspicious outbreak clusters. Findings triggered a prospective genomic surveillance period from days 342 to 558 during which MRSA isolates from all nasal-perirectal swab cultures and diagnostic cultures were sequenced, in addition to the previously collected strains. Medical records for NICU patients during the surveillance period were evaluated for clinical diagnoses, reasons for NICU admission, and additional culture-based analyses. In the context of the clinical genomic surveillance program, only patient surveillance and diagnostic strains were evaluated. Non-clinical samples were not collected from patient family members or NICU personnel. Neonates colonized or infected with MRSA were placed in single rooms and managed with Contact Precautions.

Sample collection

BD BBL CultureSwabs (BD, San Jose, CA) were used for nasal-perirectal (NP) screening for S. aureus. Swabs were cultured to colistin nalidixic acid (CNA) blood agar for 18-24 hours at 37°C. S. aureus colonies were identified by colony morphology, Gram stain and positive catalase and coagulase assays (Thermo). Diagnostic cultures with putative S. aureus colonies were evaluated similarly. One MRSA isolate from a patient that tested positive on a single nasal-perirectal screening swab was missed during the surveillance period and excluded from the study. Collected isolates were preserved at -80° C in 2ml Cryovials (Corning, Corning, NY). In the context of the clinical genomic surveillance program, and the IRB protocol under which it operates, only patient surveillance and diagnostic strains were evaluated. Non-clinical samples were not collected from patient family members or NICU personnel.

Antibiotic resistance testing

S. aureus isolates were tested clinically for antibiotic resistance by VITEK 2 with Susceptibility Card AST-GP78 (Biomerieux, Durham, NC). Microdilution testing for fusidic acid resistance was done by broth microdilution according to CLSI guidelines57. MRSA isolates were called by resistance to cefoxitin.

Genome sequencing

All isolate genomes were sequenced using Illumina NextSeq as described (Illumina, San Diengo, CA)56. Oxford nanopore sequencing (Oxford Nanopore, Cambridge, MA) and subsequent assembly using a combination of nanopore and Illumina reads was performed as previously described for MLST 1535 isolates58. Datasets were deposited under NCBI Bioproject PRJNA278886.

Bioinformatic analyses

Patient data was visualized and analyzed using Python with the packages Matplotlib and SciPy59,60. Isolate genome sequencing reads were uploaded to the NCBI Sequence Read Archive for inclusion in the Pathogen Detection program (Supplemental table 1), which includes SNP clustering, virulence gene detection, antimicrobial resistance gene detection, and isolate metadata61. Phylogenetic results were visualized using the Pathogen Detection Isolates Browser.

Whole-genome MLST was performed using the program tblastn and coding sequences from RefSeq genome NC_007795.162,63. The threshold for inclusion was an e-value ≤0.001 and a length between 0.5x and 1.5x the reference sequence coding length. Gene matches were retained if there was at most one high quality hit in each genome for all genomes in a downsampled set of all S. aureus isolate genomes available in the NCBI Pathogen Detection program, limited to 5 from each SNP cluster. Gene sequences were only kept if they matched the reference sequence length to allow for efficient SNP calculation across thousands of genomes. Genes were excluded if present in <90% of genomes, resulting in a database of 2021 genes. Genomes with <90% of these genes represented within the criteria above were excluded, resulting in a final database representing 15,477 genomes. From this set of genomic information, allelic differences were calculated to determine the closest set of 25 genomes to NICU MRSA isolates, keeping all tied for 25th closest. SNP matrices were then created using the gene encoding sequences among these ≌25 genomes plus the NICU MRSA isolates. Phylogenies from these matrices were calculated with RAxML 8.2.11 using 1000 bootstraps and the GTR substitution matrix64.

Each strain’s MLST was calculated using the reference sequences and definitions from pubMLST.org65. SCCmec types were determined using the tools and guidelines from SCCmec Finder66. Virulence gene profiles and antibiotic resistance gene profiles were taken from the analysis at the NCBI Pathogen Detection Program 61.

Annotation of the MLST 1535 SCCmec region was performed as follows. First, the genome was annotated by the PATRIC RASTtk-enabled Genome Annotation Service67. Open reading frames within this sequence were confirmed or identified using blastp searches against the non-redundant protein sequences database at NCBI63. Cassette chromosome recombinase (ccr) gene identity was investigated using blastp and representative alleles using hits above 80% identity and length40,68.

Data Availability

MRSA strain genomic data are available under NCBI BioProject PRJNA278886.

https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA278886

Acknowledgements

The authors wish to thank Mary Delaney for clinical microbiologic support, the Wadsworth Center Advanced Genomic Technologies Center (AGTC) for sequencing, and Beth Flanigan, MD for helpful review of results. The work of JW was supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health, and the work of JC by the BWH Clinical Microbiology Fellowship. Studies were supported by P30 DK034854 (Bry). Sequencing at the AGTC was supported by FDA Cooperative Agreements 5U18FD006229 and 1U18FD006763 (Wolfgang).

References

  1. ↵
    Sievert, D. M. et al. Antimicrobial-resistant pathogens associated with healthcare- associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infection Control and Hospital Epidemiology 34, 1–14, doi:10.1086/668770 (2013).
    OpenUrlCrossRefPubMed
  2. ↵
    Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L. & Fowler, V. G. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews 28, 603–661, doi:10.1128/CMR.00134-14 (2015).
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Nelson, M. U. & Gallagher, P. G. Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Seminars in Perinatology 36, 424–430, doi:10.1053/j.semperi.2012.06.004 (2012).
    OpenUrlCrossRefPubMed
  4. ↵
    Huang, Y.-C., Chou, Y.-H., Su, L.-H., Lien, R.-I. & Lin, T.-Y. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 118, 469–474, doi:10.1542/peds.2006-0254 (2006).
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Zervou, F. N., Zacharioudakis, I. M., Ziakas, P. D. & Mylonakis, E. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics 133, e1015–1023, doi:10.1542/peds.2013-3413 (2014).
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Gerber, S. I. et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infection Control and Hospital Epidemiology 27, 139–145, doi:10.1086/501216 (2006).
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Milstone, A. M. et al. Effect of treating parents colonized with Staphylococcus aureus on transmission to neonates in the intensive care unit: a randomized clinical trial. JAMA 323, 319–328, doi:10.1001/jama.2019.20785 (2020).
    OpenUrlCrossRef
  8. ↵
    Gastmeier, P. et al. Outbreaks in neonatal intensive care units - they are not like others. American Journal of Infection Control 35, 172–176, doi:10.1016/j.ajic.2006.07.007 (2007).
    OpenUrlCrossRefPubMedWeb of Science
  9. Gastmeier, P., Sohr, D., Geffers, C., Behnke, M. & Rüden, H. Risk factors for death due to nosocomial infection in intensive care unit patients: findings from the Krankenhaus Infektions Surveillance System. Infection Control and Hospital Epidemiology 28, 466–472, doi:10.1086/510810 (2007).
    OpenUrlCrossRefPubMedWeb of Science
  10. Conceição, T. et al. Staphylococcus aureus reservoirs and transmission routes in a Portuguese neonatal intensive care unit: a 30-month surveillance study. Microbial Drug Resistance (Larchmont, N.Y.) 18, 116–124, doi:10.1089/mdr.2011.0182 (2012).
    OpenUrlCrossRefPubMed
  11. ↵
    Dong, Y., Glaser, K. & Speer, C. P. New threats from an old foe: methicillin-resistant Staphylococcus aureus infections in neonates. Neonatology 114, 127–134, doi:10.1159/000488582 (2018).
    OpenUrlCrossRef
  12. ↵
    Sakaki, H., Nishioka, M., Kanda, K. & Takahashi, Y. An investigation of the risk factors for infection with methicillin-resistant Staphylococcus aureus among patients in a neonatal intensive care unit. American Journal of Infection Control 37, 580–586, doi:10.1016/j.ajic.2009.02.008 (2009).
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Washam, M., Woltmann, J., Haberman, B., Haslam, D. & Staat, M. A. Risk factors for methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: a systematic review and meta-analysis. American Journal of Infection Control 45, 1388–1393, doi:10.1016/j.ajic.2017.06.021 (2017).
    OpenUrlCrossRef
  14. ↵
    Raboud, J. et al. Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital. Infection Control and Hospital Epidemiology 26, 607–615, doi:10.1086/502589 (2005).
    OpenUrlCrossRefPubMedWeb of Science
  15. Laing, I. A., Gibb, A. P. & McCallum, A. Controlling an outbreak of MRSA in the neonatal unit: a steep learning curve. Archives of Disease in Childhood. Fetal and Neonatal Edition 94, F307–310, doi:10.1136/adc.2008.151290 (2009).
    OpenUrlAbstract/FREE Full Text
  16. Geva, A. et al. Spread of methicillin-resistant Staphylococcus aureus in a large tertiary NICU: network analysis. Pediatrics 128, e1173–1180, doi:10.1542/peds.2010-2562 (2011).
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Price, J. R. et al. Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 58, 609–618, doi:10.1093/cid/cit807 (2014).
    OpenUrlCrossRefPubMed
  18. ↵
    Bertin, M. L. et al. Outbreak of methicillin-resistant Staphylococcus aureus colonization and infection in a neonatal intensive care unit epidemiologically linked to a healthcare worker with chronic otitis. Infection Control and Hospital Epidemiology 27, 581–585, doi:10.1086/504933 (2006).
    OpenUrlCrossRefPubMedWeb of Science
  19. Méan, M. et al. A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns. Infection Control and Hospital Epidemiology 28, 625–628, doi:10.1086/513616 (2007).
    OpenUrlCrossRefPubMed
  20. ↵
    Price, J. R. et al. Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study based on whole-genome sequencing. The Lancet. Infectious Diseases 17, 207–214, doi:10.1016/S1473-3099(16)30413-3 (2017).
    OpenUrlCrossRef
  21. ↵
    Morel, A.-S. et al. Nosocomial transmission of methicillin-resistant Staphylococcus aureus from a mother to her preterm quadruplet infants. American Journal of Infection Control 30, 170–173, doi:10.1067/mic.2002.119819 (2002).
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Al-Tawfiq, J. A. Father-to-infant transmission of community-acquired methicillin- resistant Staphylococcus aureus in a neonatal intensive care unit. Infection Control and Hospital Epidemiology 27, 636–637, doi:10.1086/505097 (2006).
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    Cheng, V. C. C. et al. Whole-genome sequencing data-based modeling for the investigation of an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 38, 563–573, doi:10.1007/s10096-018-03458-y (2019).
    OpenUrlCrossRef
  24. ↵
    Albrich, W. C. & Harbarth, S. Health-care workers: source, vector, or victim of MRSA? The Lancet. Infectious Diseases 8, 289–301, doi:10.1016/S1473-3099(08)70097-5 (2008).
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Lessa, F. C. et al. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004. The Pediatric Infectious Disease Journal 28, 577–581, doi:10.1097/INF.0b013e31819988bf (2009).
    OpenUrlCrossRefPubMed
  26. ↵
    Köser, C. U. et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. The New England Journal of Medicine 366, 2267–2275, doi:10.1056/NEJMoa1109910 (2012).
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Price, J. R., Didelot, X., Crook, D. W., Llewelyn, M. J. & Paul, J. Whole genome sequencing in the prevention and control of Staphylococcus aureus infection. The Journal of Hospital Infection 83, 14–21, doi:10.1016/j.jhin.2012.10.003 (2013).
    OpenUrlCrossRefPubMed
  28. Azarian, T. et al. Whole-genome sequencing for outbreak investigations of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit: time for routine practice? Infection Control and Hospital Epidemiology 36, 777–785, doi:10.1017/ice.2015.73 (2015).
    OpenUrlCrossRefPubMed
  29. ↵
    Roisin, S. et al. Pan-genome multilocus sequence typing and outbreak-specific reference-based single nucleotide polymorphism analysis to resolve two concurrent Staphylococcus aureus outbreaks in neonatal services. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 22, 520–526, doi:10.1016/j.cmi.2016.01.024 (2016).
    OpenUrlCrossRef
  30. ↵
    Lakhundi, S. & Zhang, K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clinical Microbiology Reviews 31, doi:10.1128/CMR.00020-18 (2018).
    OpenUrlAbstract/FREE Full Text
  31. ↵
    SenGupta, D. J. et al. Whole-genome sequencing for high-resolution investigation of methicillin-resistant Staphylococcus aureus epidemiology and genome plasticity. Journal of Clinical Microbiology 52, 2787–2796, doi:10.1128/JCM.00759-14 (2014).
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Harris, S. R. et al. Whole-genome sequencing for analysis of an outbreak of meticillin- resistant Staphylococcus aureus: a descriptive study. The Lancet. Infectious Diseases 13, 130–136, doi:10.1016/S1473-3099(12)70268-2 (2013).
    OpenUrlCrossRef
  33. Layer, F. et al. Molecular typing of toxic shock syndrome toxin-1- and Enterotoxin A- producing methicillin-sensitive Staphylococcus aureus isolates from an outbreak in a neonatal intensive care unit. International journal of medical microbiology: IJMM 305, 790–798, doi:10.1016/j.ijmm.2015.08.033 (2015).
    OpenUrlCrossRef
  34. ↵
    Earls, M. R. et al. Intra-hospital, inter-hospital and intercontinental spread of ST78 MRSA from two neonatal intensive care unit outbreaks established using whole-genome sequencing. Frontiers in Microbiology 9, 1485, doi:10.3389/fmicb.2018.01485 (2018).
    OpenUrlCrossRef
  35. ↵
    Sullivan, M. J. et al. A complete genome screening program of clinical methicillin- resistant Staphylococcus aureus isolates identifies the origin and progression of a neonatal intensive care unit outbreak. Journal of Clinical Microbiology 57, doi:10.1128/JCM.01261-19 (2019).
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Nübel, U. et al. MRSA transmission on a neonatal intensive care unit: epidemiological and genome-based phylogenetic analyses. PloS One 8, e54898, doi:10.1371/journal.pone.0054898 (2013).
    OpenUrlCrossRefPubMed
  37. ↵
    Prosperi, M. et al. Molecular epidemiology of community-associated methicillin- resistant Staphylococcus aureus in the genomic era: a cross-sectional study. Scientific Reports 3, 1902, doi:10.1038/srep01902 (2013).
    OpenUrlCrossRefPubMed
  38. ↵
    Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrobial Agents and Chemotherapy 53, 4961–4967, doi:10.1128/AAC.00579-09 (2009).
    OpenUrlFREE Full Text
  39. ↵
    Lin, Y.-T. et al. A novel staphylococcal cassette chromosomal element, SCCfusC, carrying fusC and speG in fusidic acid-resistant methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 58, 1224–1227, doi:10.1128/AAC.01772-13 (2014).
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Senok, A. C. et al. Investigating a rare methicillin-resistant Staphylococcus aureus strain: first description of genome sequencing and molecular characterization of CC15-MRSA. Infection and Drug Resistance 10, 307–315, doi:10.2147/IDR.S145394 (2017).
    OpenUrlCrossRef
  41. ↵
    Ankrum, A. & Hall, B. G. Population dynamics of Staphylococcus aureus in cystic fibrosis patients to determine transmission events by use of whole-genome sequencing. Journal of Clinical Microbiology 55, 2143–2152, doi:10.1128/JCM.00164-17 (2017).
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Worley, J. et al. Genomic determination of relative risks for Clostridioides difficile infection from asymptomatic carriage in ICU patients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, doi:10.1093/cid/ciaa894 (2020).
    OpenUrlCrossRef
  43. Orsi, R. H. et al. Short-term genome evolution of Listeria monocytogenes in a noncontrolled environment. BMC Genomics 9, 539, doi:10.1186/1471-2164-9-539 (2008).
    OpenUrlCrossRefPubMed
  44. Narui, K. et al. Change in environmental bacterial flora in a new hospital building. The Journal of Hospital Infection 73, 24–33, doi:10.1016/j.jhin.2009.05.019 (2009).
    OpenUrlCrossRefPubMed
  45. ↵
    Stasiewicz, M. J., Oliver, H. F., Wiedmann, M. & den Bakker, H. C. Whole-genome sequencing allows for improved identification of persistent Listeria monocytogenes in food-associated environments. Applied and Environmental Microbiology 81, 6024–6037, doi:10.1128/AEM.01049-15 (2015).
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Williamson, D. A. et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 59, 1451–1454, doi:10.1093/cid/ciu658 (2014).
    OpenUrlCrossRefPubMed
  47. Cabrera, R. et al. Molecular characterization of methicillin-resistant Staphylococcus aureus clinical strains from the endotracheal tubes of patients with nosocomial pneumonia. Antimicrobial Resistance and Infection Control 9, 43, doi:10.1186/s13756-020-0679-z (2020).
    OpenUrlCrossRef
  48. ↵
    Senok, A. et al. Genotyping of methicillin resistant Staphylococcus aureus from the United Arab Emirates. Scientific Reports 10, 18551, doi:10.1038/s41598-020-75565-w (2020).
    OpenUrlCrossRef
  49. ↵
    Ellington, M. J. et al. Emergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents 45, 477–484, doi:10.1016/j.ijantimicag.2015.01.009 (2015).
    OpenUrlCrossRefPubMed
  50. Baines, S. L. et al. Rapid emergence and evolution of Staphylococcus aureus clones harboring fusC-containing staphylococcal cassette chromosome elements. Antimicrobial Agents and Chemotherapy 60, 2359–2365, doi:10.1128/AAC.03020-15 (2016).
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Senok, A. et al. Characterisation of a novel SCCmec VI element harbouring fusC in an emerging Staphylococcus aureus strain from the Arabian Gulf region. PLoS ONE 14, doi:10.1371/journal.pone.0223985 (2019).
    OpenUrlCrossRef
  52. ↵
    Monecke, S. et al. Characterisation of MRSA strains isolated from patients in a hospital in Riyadh, Kingdom of Saudi Arabia. BMC Microbiology 12, 146, doi:10.1186/1471-2180-12-146 (2012).
    OpenUrlCrossRefPubMed
  53. ↵
    Udo, E. E. et al. Emergence of methicillin-resistant Staphylococcus aureus belonging to clonal complex 15 (CC15-MRSA) in Kuwait hospitals. Infection and Drug Resistance 13, 617–626, doi:10.2147/IDR.S237319 (2020).
    OpenUrlCrossRef
  54. ↵
    Larsen, J., Andersen, P. S., Winstel, V. & Peschel, A. Staphylococcus aureus CC395 harbours a novel composite staphylococcal cassette chromosome mec element. The Journal of Antimicrobial Chemotherapy 72, 1002–1005, doi:10.1093/jac/dkw544 (2017).
    OpenUrlCrossRefPubMed
  55. ↵
    Murphy, S. et al. Instrumenting the health care enterprise for discovery research in the genomic era. Genome Research 19, 1675–1681, doi:10.1101/gr.094615.109 (2009).
    OpenUrlAbstract/FREE Full Text
  56. ↵
    Nudel, K. et al. Genomics of Corynebacterium striatum, an emerging multi-drug resistant pathogen of immunocompromised patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 24, 1016.e1017-1016.e1013, doi:10.1016/j.cmi.2017.12.024 (2018).
    OpenUrlCrossRef
  57. ↵
    CLSI. Methods for dilution antimicrobial susceptiblity tests for bacteria that grow aerobically. 11 edn, Vol. M07 (Clinical and Laboratory Standards Institute, 2018).
  58. ↵
    Gonzalez-Escalona, N. & Sharma, S. K. Closing Clostridium botulinum group I genomes using a combination of short- and long-reads. Frontiers in Microbiology 11, doi:10.3389/fmicb.2020.00239 (2020).
    OpenUrlCrossRef
  59. ↵
    Hunter, J. D. Matplotlib: a 2D graphics environment. Computing in Science & Engineering 9, 90–95, doi:10.1109/MCSE.2007.55 (2007).
    OpenUrlCrossRef
  60. ↵
    Virtanen, P. et al. SciPy 1.0 – fundamental algorithms for scientific computing in Python. Nature Methods 17, 261–272 (2020).
    OpenUrl
  61. ↵
    (National Library of Medicine (US), National Center for Biotechnology Information, 2016).
  62. ↵
    Gillaspy, A. F. et al. in Gram-Positive Pathogens 381-412 (John Wiley & Sons, Ltd, 2006).
  63. ↵
    Camacho, C. et al. BLAST+: architecture and applications. BMC bioinformatics 10, 421, doi:10.1186/1471-2105-10-421 (2009).
    OpenUrlCrossRefPubMed
  64. ↵
    Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics (Oxford, England) 30, 1312–1313, doi:10.1093/bioinformatics/btu033 (2014).
    OpenUrlCrossRefPubMedWeb of Science
  65. ↵
    Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Research 3, doi:10.12688/wellcomeopenres.14826.1 (2018).
    OpenUrlCrossRefPubMed
  66. ↵
    Kaya, H. et al. SCCmecFinder, a web-based tool for typing of staphylococcal cassette chromosome mec in Staphylococcus aureus using whole-genome sequence data. mSphere 3, doi:10.1128/mSphere.00612-17 (2018).
    OpenUrlAbstract/FREE Full Text
  67. ↵
    Brettin, T. et al. RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Scientific Reports 5, doi:10.1038/srep08365 (2015).
    OpenUrlCrossRefPubMed
  68. ↵
    Monecke, S. et al. Diversity of SCCmec elements in Staphylococcus aureus as observed in South-Eastern Germany. PloS One 11, e0162654, doi:10.1371/journal.pone.0162654 (2016).
    OpenUrlCrossRefPubMed
Back to top
Posted July 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Prospective genomic surveillance reveals cryptic MRSA outbreaks with local to international origins among NICU patients
Jay N. Worley, Jessica W. Crothers, William J. Wolfgang, Sai Laxmi Gubbala Venkata, Maria Hoffmann, Victor Jayeola, Michael Klompas, Marc Allard, Lynn Bry
medRxiv 2021.07.14.21260339; doi: https://doi.org/10.1101/2021.07.14.21260339
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area